Inventor · disambiguated record
Peter Haeberli
Also filed as: HAEBERLI PETER
9 granted patents·44 pending applications·1,183 citations·filing 1996–2014
93Inventor score
Top patents by PatentIndex Score
53 records- 0198US7491805B2Conjugates and compositions for cellular deliverySIRNA THERAPEUTICS INC·Filed 2004·Granted Feb 17, 2009·273 cites·4 claims
- 0298US6673611B2Nucleic acid molecules with novel chemical compositions capable of modulating gene expressionSIRNA THERAPEUTICS INC·Filed 2001·Granted Jan 6, 2004·218 cites·17 claims
- 0397US7964578B2Conjugates and compositions for cellular deliverySIRNA THERAPEUTICS INC·Filed 2008·Granted Jun 21, 2011·66 cites·9 claims
- 0497US7833992B2Conjugates and compositions for cellular deliveryMERCK SHARPE & DOHME·Filed 2003·Granted Nov 16, 2010·149 cites·3 claims
- 0597US6395713B1Compositions for the delivery of negatively charged moleculesRIBOZYME PHARM INC·Filed 1998·Granted May 28, 2002·367 cites·13 claims
- 0695US7553830B2Compositions for the delivery of negatively charged moleculesSIRNA THERAPEUTICS INC·Filed 2005·Granted Jun 30, 2009·20 cites·10 claims
- 0790US6686463B2Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivativesSIRNA THERAPEUTICS INC·Filed 2001·Granted Feb 3, 2004·59 cites·75 claims
- 0883US6972330B2Chemical synthesis of methoxy nucleosidesSIRNA THERAPEUTICS INC·Filed 2003·Granted Dec 6, 2005·16 cites·12 claims
- 0973US2010036115A1Novel Compositions for the Delivery of Negatively Charged MoleculesSIRNA THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1070US2006292691A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1170US2007004667A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1268US2006247429A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1368US2006287266A1RNA interference mediated ihibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1468US2006217336A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1565US2006281175A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1665US2006275903A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1763US5962675AChemical syntheses of 2'-O-methoxy purine nucleosidesRIBOZYME PHARM INC·Filed 1996·Granted Oct 5, 1999·15 cites·12 claims
- 1863US2006217337A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1963US2006247428A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2063US2006217335A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2163US2006217334A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2260US2005222064A1Polycationic compositions for cellular delivery of polynucleotidesSIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 2359US2007026394A1Modulation of gene expression associated with inflammation proliferation and neurite outgrowth using nucleic acid based technologiesBLATT LAWRENCE·Filed 2002·Application pending·0 cites
- 2458US2005176018A1Chemically modified double stranded nucleic acid moleculesSIRNA THERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 2557US2008249294A1RNA Interference Mediated Inhibition of Gene Expression Using Short Interfering Nucleic Acid (siNA)SIRNA THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 2657US2005159382A1RNA interference mediated inhibition of polycomb group protein EZH2 gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 2757US2007042983A1RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 2857US2009023676A1RNA Interference Mediated Inhibition of MAP Kinase Gene Expression or Expression of Genes Involved in MAP Kinase Pathway Using Short Interfering Nucleic Acid (SiNA)SIRNA THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 2957US2008033156A1Polycationic compositions for cellular delivery of polynucleotidesSIRNA THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 3056US2005182008A1RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 3155US2007270360A1Rna Interference Mediated Inhibition of Severe Acute Respiratory Syndrome (Sars) Gene Expression Using Short Interfering Nucleic AcidSIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 3255US2005059817A1Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivativesSIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 3354US2005136436A1RNA interference mediated inhibition of G72 and D-amino acid oxidase (DAAO) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 3454US2005239731A1RNA interference mediated inhibition of MAP kinase gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 3553US2005119212A1RNA interference mediated inhibition of FAS and FASL gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 3653US2011124853A1Conjugates and Compositions for Cellular DeliveryCHEN TONGQIAN·Filed 2010·Application pending·0 cites
- 3753US2007160980A1RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 3853US2007185043A1Rna interference mediated inhibition of nogo and nogo receptor gene expression using short interfering nucleic acid (sina)SIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 3952US2015105445A1RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)SIRNA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4051US2005282188A1RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 4151US2005209182A1Nucleic acid mediated inhibition of enterococcus infection and cytolysin toxin activitySIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 4251US2004219671A1RNA interference mediated treatment of parkinson disease using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 4350US2005020525A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 4448US2006127891A1RNA interference mediated inhibition of MAP kinase gene expression or expression of genes involved in MAP kinase pathway using short interfering nucleic acid (siNA)MCSWIGGEN JAMES·Filed 2003·Application pending·0 cites
- 4547US2002150936A1Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivativesFiled 2002·Application pending·0 cites
- 4646US2003060611A1Method and reagent for the inhibition of NOGO geneFiled 2001·Application pending·0 cites
- 4745US2003065155A1Nucleic acid sensor moleculesFiled 2002·Application pending·0 cites
- 4845US2003073640A1Novel compositions for the delivery of negatively charged moleculesRIBOZYME PHARM INC·Filed 2001·Application pending·0 cites
- 4944US2003008295A1Nucleic acid sensor moleculesFiled 2001·Application pending·0 cites
- 5044US2003203870A1Method and reagent for the inhibition of NOGO and NOGO receptor genesRIBOZYME PHARM INC·Filed 2003·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Peter Haeberli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →